ESR2 and breast cancer: Studies indicate that patients with luminal B breast cancer have a higher local recurrence rate compared to patients with non‐luminal breast cancer.[4] This subtype is characterized by being ERα negative, ERβ positive, PR positive, and HER2 positive.[5]